105 studies found for:    Open Studies | "Nasopharyngeal Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Nasopharyngeal Carcinoma Post IMRT
Condition: Nasopharyngeal Carcinoma
Intervention:
22 Recruiting A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Recombinant Human Endostatin Injection (Endostar);   Drug: Fluorouracil (5-Fu);   Drug: Nedaplatin
23 Not yet recruiting Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China
Condition: Nasopharyngeal Cancinoma (NPC)
Intervention:
24 Recruiting NBI to Detect Post-RT Mucosal Residual NPC
Condition: Nasopharyngeal Carcinoma
Intervention: Device: Laryngoscope with NBI system
25 Recruiting Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Conditions: Current Smoker;   Head and Neck Squamous Cell Carcinoma;   Hypopharyngeal Squamous Cell Carcinoma;   Laryngeal Squamous Cell Carcinoma;   Nasopharyngeal Carcinoma;   Oral Cavity Squamous Cell Carcinoma;   Oropharyngeal Squamous Cell Carcinoma
Interventions: Drug: Bupropion Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Nicotine Replacement;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: Varenicline
26 Recruiting Multicentre, Randomized, Open-Label, Phase III Clinical Trial for Advanced Nasopharyngeal Carcinoma Patients
Condition: Nasopharyngeal Cancer
Interventions: Biological: autologous EBV specific Cytotoxic T Lymphocytes;   Drug: combination IV gemcitabine and IV carboplatin (AUC2)
27 Recruiting Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients
Conditions: Nasopharyngeal Carcinoma;   Malnutrition
Intervention: Drug: cisplatin and docetaxel
28 Recruiting Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Radiation: CIRT arm
29 Recruiting Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: raltitrexed-cisplatin;   Radiation: Intensity-modulated radiotherapy (IMRT)
30 Recruiting Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery
Conditions: Head and Neck Squamous Cell Carcinoma;   Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Recurrent Nasopharynx Carcinoma;   Recurrent Salivary Gland Carcinoma;   Salivary Gland Carcinoma;   Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary;   Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage III Nasopharyngeal Carcinoma;   Stage IV Nasopharyngeal Carcinoma;   Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Drug: Vorinostat
31 Recruiting The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Celecoxib;   Drug: Nedaplatin;   Radiation: Concurrent Radiotherapy
32 Recruiting HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Procedure: interventional therapy
33 Not yet recruiting A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Docetaxel (DOC);   Drug: Cisplatin (DDP);   Radiation: Concurrent chemoradiation (CRT)
34 Not yet recruiting Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Radiation: Chemoradiotherapy for nasopharyngeal carcinoma
35 Recruiting Nasopharyngeal Carcinoma Screening in Zhongshan City
Condition: Nasopharyngeal Carcinoma
Intervention:
36 Recruiting Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin;   Drug: Fluorouracil;   Radiation: Radiation therapy;   Drug: Leucovorin
37 Recruiting Polymorphisms in Key Genes of Glycolytic Pathway: Influence on Radiosensitivity in Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma;   Single Nucleotide Polymorphisms;   Radiosensitivity
Intervention: Other: validation group
38 Recruiting Serial Plasma EBV DNA for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention:
39 Not yet recruiting The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Gemcitabine;   Drug: cisplatin;   Radiation: Intensity-modulated Radiotherapy
40 Recruiting Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: capecitabine;   Other: Best supportive care (BSC)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years